Arthur A. Levin, Chief Scientific Officer at Avidity Biosciences, Inc. (RNA), sold 19,477 shares at $23.62 ($460K) on 2023-02-14, disclosed to the SEC on 2023-02-15.
Open-market sale of $460k RNA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.62 | 9,477 | $224K | 48.6% |
| 2 | $23.62 | 9,477 | $224K | 48.6% |
| 3 | $24.24 | 523 | $13K | 2.8% |
| Total | $23.64 avg | 19,477 | $460K | 100% |
| Filing → |
| RNA | SELL | 2025-08-08 | $5.1M | — | Filing → |
| RNA | SELL | 2025-01-23 | $107K | — | Filing → |
| RNA | SELL | 2024-11-20 | $280K | — | Filing → |